| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.44 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.44 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.37 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.08 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.1 | 0.07 |